Development and Application of Tumor Organoids: An Emerging Platform for Gynecological Cancers
Yu Hu, Wei Chen, Xiaojing Zhang, Ying Wu, Furong Du, Jingrui Wang, Meijun He, Wei Sun · 2025
Read Development and Application of Tumor Organoids: An Emerging Platform for Gynecological Cancers by Yu Hu, Wei Chen, Xiaojing Zhang, Ying Wu, Furong Du, Jingrui Wang, Meijun He, Wei Sun (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12764298.txt.
Description
Yu Hu and seven co-authors review tumor organoids as a new platform for gynecological cancers, in work from 2025. Ovarian, cervical and endometrial cancers are the most common of these, and standard care is often blunted by drug resistance and relapse. Organoids are three-dimensional cultures grown from stem cells that copy the look and behaviour of real tissue.
Tumor organoids keep each patient's marker profile and genome, and they show varied drug responses both between and within patients. The review covers how the models are built and used, from probing how tumors form to screening drugs and tailoring treatment. The authors present organoids as a step toward care matched to the individual patient.
Catalog record
| CREATOR | Yu Hu, Wei Chen, Xiaojing Zhang, Ying Wu, Furong Du, Jingrui Wang, Meijun He, Wei Sun |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |